Hamdard Laboratories: The Shift Towards Allopathic Generic Medicine Market

With an eye on expansion, Hamdard Laboratories, country’s oldest Unani medicine manufacturer, is aiming for INR 500 crore revenue in FY26-27. The company is also targeting to enter allopathic generic medicine in the next five years. This move marks a shift towards strengthening Hamdard’s footprint in the overall pharmaceutical industry, blending its heritage in herbal and Unani medicine with modern generic healthcare demands.